Search Results - "van Schaik, Ivo N."

Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies.

Authors: Merkies, Ingemar S.J. van Schaik, Ivo N. Léger, Jean‐Marc et al.

Source: Journal of the Peripheral Nervous System. Mar2019, Vol. 24 Issue 1, p48-55. 8p.

Analysis of relapse by inflammatory Rasch‐built overall disability scale status in the PATH study of subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy.

Authors: Merkies, Ingemar S. J. van Schaik, Ivo N. Bril, Vera et al.

Source: Journal of the Peripheral Nervous System. Jun2022, Vol. 27 Issue 2, p159-165. 7p.

Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.

Authors: Adrichem, Max E. Lucke, Ilse M. Vrancken, Alexander F. J. E. et al.

Source: Brain: A Journal of Neurology; May2022, Vol. 145 Issue 5, p1641-1652, 12p

Intravenous versus subcutaneous immunoglobulin - Authors' reply.

Authors: van Schaik, Ivo N Mielke, Orell PATH study group

Source: Lancet Neurology. May2018, Vol. 17 Issue 5, p393-394. 2p.

Validity and Responsiveness of Balance Measurements Using Posturography in Patients With Immune‐Mediated Neuropathies.

Authors: Michael, Milou R. van Veen, Robin Wieske, Luuk et al.

Source: Journal of the Peripheral Nervous System. Jun2025, Vol. 30 Issue 2, p1-10. 10p.

Pharmacometric analysis linking immunoglobulin exposure to clinical efficacy outcomes in chronic inflammatory demyelinating polyneuropathy.

Authors: Tortorici, Michael A. Yuraszeck, Theresa Cornblath, David et al.

Source: CPT: Pharmacometrics & Systems Pharmacology. Aug2021, Vol. 10 Issue 8, p839-850. 12p.

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial.

Authors: van Schaik, Ivo N. van Geloven, Nan Bril, Vera et al.

Source: Trials. 7/25/2016, Vol. 17, p1-15. 15p. 1 Diagram, 4 Charts.

Autonomic neuropathy in Fabry disease: a prospective study using the Autonomic Symptom Profile and cardiovascular autonomic function tests.

Authors: Biegstraaten, Marieke van Schaik, Ivo N. Wieling, Wouter et al.

Source: BMC Neurology. 2010, Vol. 10, p38-46. 9p.

Challenges in the Early Diagnosis and Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Adults: Current Perspectives.

Authors: van Doorn, Iris N Eftimov, Filip Wieske, Luuk et al.

Source: Therapeutics & Clinical Risk Management. Feb2024, Vol. 20, p111-126. 16p.

Early Prediction of Intensive Care Unit–Acquired Weakness Using Easily Available Parameters: A Prospective Observational Study.

Authors: Wieske, Luuk Witteveen, Esther Verhamme, Camiel et al.

Source: PLoS ONE. Oct2014, Vol. 9 Issue 10, p1-8. 8p.

Depressive symptoms in Fabry disease: the importance of coping, subjective health perception and pain.

Authors: Körver, Simon Geurtsen, Gert J. Hollak, Carla E. M. et al.

Source: Orphanet Journal of Rare Diseases. 1/28/2020, Vol. 15 Issue 1, p1-9. 9p.

The natural history of Charcot-Marie-Tooth type 1A in adults: a 5-year follow-up study.

Authors: Verhamme C van Schaik IN Koelman JH et al.

Source: Brain: A Journal of Neurology; Dec2009, Vol. 132 Issue 12, p3252-3262, 11p

Diagnosis and treatment response in the asymmetric variant of chronic inflammatory demyelinating polyneuropathy.

Authors: Lucke, Ilse M. Wieske, Luuk van der Kooi, Anneke J. et al.

Source: Journal of the Peripheral Nervous System. Jun2019, Vol. 24 Issue 2, p174-179. 6p.

Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post‐hoc analysis of the immunoglobulin overtreatment in CIDP trial.

Authors: van Veen, Robin Wieske, Luuk Lucke, Ilse et al.

Source: Journal of the Peripheral Nervous System. Jun2022, Vol. 27 Issue 2, p144-158. 15p.

Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy, a time to start and a time to stop.

Authors: Adrichem, Max E. Eftimov, Filip van Schaik, Ivo N.

Source: Journal of the Peripheral Nervous System. Sep2016, Vol. 21 Issue 3, p121-127. 7p.

Deterioration after corticosteroids in CIDP may be associated with pure focal demyelination pattern.

Authors: Eftimov, Filip Liesdek, Marinus H. Verhamme, Camillus et al.

Source: BMC Neurology. 2014, Vol. 14 Issue 1, p1-12. 12p. 1 Diagram, 2 Charts.

Subcutaneous immunoglobulin therapy for multifocal motor neuropathy.

Authors: Eftimov, Filip Vermeulen, Marinus de Haan, Rob J. et al.

Source: Journal of the Peripheral Nervous System. Jun2009, Vol. 14 Issue 2, p93-100. 8p. 1 Diagram, 4 Charts, 1 Graph.

European Federation of Neurological Societies/Peripheral Nerve Society Guideline.

Authors: Hughes, Richard A. C. Bouche, Pierre Cornblath, David R. et al.

Source: Journal of the Peripheral Nervous System. Sep2005, Vol. 10 Issue 3, p220-228. 9p.

Predictors of objective cognitive impairment and subjective cognitive complaints in patients with Fabry disease.

Authors: Körver, Simon Geurtsen, Gert J. Hollak, Carla E. M. et al.

Source: Scientific Reports. 1/17/2019, Vol. 9 Issue 1, p1-1. 1p.

Defining persistent critical illness based on growth trajectories in patients with sepsis.

Authors: Zhang Z Ho KM Gu H et al.

Source: Critical care (London, England) [Crit Care] 2020 Feb 18; Vol. 24 (1), pp. 57. Date of Electronic Publication: 2020 Feb 18.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 9801902 Publication Model: Electronic Cited Medium: Internet ISSN: 1466-609X (Electronic) Linking ISSN: 13648535 NLM ISO Abbreviation: Crit Care Subsets: MEDLINE